Day: March 2, 2022

The board of directors of IDEX Biometrics ASA has resolved to issue 1,765,791 ordinary shares at NOK 1.70 per share to employees who participate in the company’s Employee Share Purchase Plan (ESPP), which plan was approved by the annual general meeting on 12 May 2021. 45 employees participated in the ESPP in this period. The participating employees have elected to invest a part of the base salary in ordinary shares in the company. Purchase takes place every six months. Following the issue, the Company’s share capital will be NOK 151,823,136.75 divided into 1,012,154,245 shares each with a nominal value of NOK 0.15. Primary insidersIDEX discloses transactions by the following primary insiders in IDEX shares ISIN NO0003070609:–   CEO Vince Graziani acquired 52,446 ordinary shares at NOK 1.70 per share.–   CTO Anthony...

In the FDA-conducted study, SAB-185 consistently demonstrated high avidity and high potency for effectively neutralizing a broad range of SARS-CoV-2 strains and variants through Delta SAB-185 additionally outperformed convalescent plasma Findings published in The Journal of Infectious Diseases SIOUX FALLS, S.D., March 01, 2022 (GLOBE NEWSWIRE) — SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the publication of nonclinical data from a study conducted in collaboration with the Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) Division of Viral Products highlighting that SAB-185 effectively neutralizes...

Holders representing approximately 62% of total Debentures extend Forbearance Period until March 14, 2022 to allow negotiations to continue TORONTO, March 01, 2022 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “Convertible Debt”). Further to the Company’s announcement on February 1, 2022, the Forbearance Agreement, entered into between the Company and holders of Convertible Debt representing approximately 58% of the aggregate principal amount of debentures outstanding, has been extended until March 14, 2022. The holders of Convertible Debt representing an additional 4% of the aggregate principal amount...